Correlation Between Sedana Medical and Hansa Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sedana Medical and Hansa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sedana Medical and Hansa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sedana Medical AB and Hansa Biopharma AB, you can compare the effects of market volatilities on Sedana Medical and Hansa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sedana Medical with a short position of Hansa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sedana Medical and Hansa Biopharma.

Diversification Opportunities for Sedana Medical and Hansa Biopharma

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Sedana and Hansa is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Sedana Medical AB and Hansa Biopharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hansa Biopharma AB and Sedana Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sedana Medical AB are associated (or correlated) with Hansa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hansa Biopharma AB has no effect on the direction of Sedana Medical i.e., Sedana Medical and Hansa Biopharma go up and down completely randomly.

Pair Corralation between Sedana Medical and Hansa Biopharma

Assuming the 90 days trading horizon Sedana Medical AB is expected to generate 1.38 times more return on investment than Hansa Biopharma. However, Sedana Medical is 1.38 times more volatile than Hansa Biopharma AB. It trades about 0.13 of its potential returns per unit of risk. Hansa Biopharma AB is currently generating about -0.09 per unit of risk. If you would invest  1,150  in Sedana Medical AB on September 3, 2024 and sell it today you would earn a total of  134.00  from holding Sedana Medical AB or generate 11.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Sedana Medical AB  vs.  Hansa Biopharma AB

 Performance 
       Timeline  
Sedana Medical AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sedana Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Hansa Biopharma AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hansa Biopharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Sedana Medical and Hansa Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sedana Medical and Hansa Biopharma

The main advantage of trading using opposite Sedana Medical and Hansa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sedana Medical position performs unexpectedly, Hansa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hansa Biopharma will offset losses from the drop in Hansa Biopharma's long position.
The idea behind Sedana Medical AB and Hansa Biopharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio